title: The impact of α-toxin on host cell plasma membrane permeability and cytokine expression during human blood infection by CA-MRSA USA300.
abstract: This investigation examines the influence of α-toxin (Hla) expression by CA-MRSA on host immune cell integrity and cytokine expression during infection of human blood. Flow cytometry analysis of human blood infected by Staphylococcus aureus PFGE type USA300 or a USA300Δhla demonstrated that Hla expression significantly increased plasma membrane permeability of human CD14(+) monocytes. The increased susceptibility of human CD14(+) monocytes to Hla toxicity paralleled the high cell-surface expression on these cell types of ADAM10. USA300 rapidly associated with PMNs and monocytes but not T cells following inoculation of human blood. Transcription analysis indicated a strong up-regulation of proinflammatory cytokine transcription following infection of human blood by USA300 and USA300Δhla. CBAs and ELISAs determined that IL-6, IL-10, TNF-α, IFN-γ, IL-1β, IL-8, and IL-4 are significantly up-regulated during the initial phases of human blood infection by USA300 relative to mock-infected blood but failed to distinguish any significant differences in secreted cytokine protein concentrations during infection by USA300Δhla relative to USA300. Collectively, these findings demonstrate that expression of Hla by USA300 has a significant impact on human CD14(+) monocyte plasma membrane integrity but is not exclusively responsible for the proinflammatory cytokine profile induced by USA300 during the initial stages of human blood infection.
authors.affiliation: 1.Lewis Hall, Montana State University, Bozeman, MT 59717, USA. jovanka@montana.edu.
authors.forename: Tyler K
authors.initials: TK
authors.lastname: Nygaard
authors.forename: Kyler B
authors.initials: KB
authors.lastname: Pallister
authors.forename: Oliwia W
authors.initials: OW
authors.lastname: Zurek
authors.forename: Jovanka M
authors.initials: JM
authors.lastname: Voyich
mesh_terms: D051722:ADAM Proteins / Q000097:blood; D000072197:ADAM10 Protein; D053829:Amyloid Precursor Protein Secretases / Q000097:blood; D016470:Bacteremia / Q000276:immunology*; D001427:Bacterial Toxins / Q000494:pharmacology*; D002463:Cell Membrane Permeability / Q000187:drug effects*; D016207:Cytokines / Q000235:genetics*; D006460:Hemolysin Proteins / Q000494:pharmacology*; D006801:Humans; D018950:Lipopolysaccharide Receptors / Q000097:blood; D008565:Membrane Proteins / Q000097:blood; D055624:Methicillin-Resistant Staphylococcus aureus; D013203:Staphylococcal Infections / Q000276:immunology*
chemical_list: D001427:Bacterial Toxins; D016207:Cytokines; D006460:Hemolysin Proteins; D018950:Lipopolysaccharide Receptors; D008565:Membrane Proteins; C021091:staphylococcal alpha-toxin; D053829:Amyloid Precursor Protein Secretases; D051722:ADAM Proteins; D000072197:ADAM10 Protein; C491236:ADAM10 protein, human
keywords: Staphylococcus aureus; T cell; chemokine; monocyte; pathogenesis; virulence
references.citation: J Immunol. 2005 Sep 15;175(6):3907-19
references.pmid: 16148137
references.citation: Curr Opin Infect Dis. 2008 Apr;21(2):147-52
references.pmid: 18317037
references.citation: Infect Immun. 2000 Jul;68(7):3965-70
references.pmid: 10858210
references.citation: J Infect Dis. 2010 Jan 15;201(2):241-54
references.pmid: 20001858
references.citation: J Infect Dis. 2009 Feb 1;199(3):294-301
references.pmid: 19115951
references.citation: Lancet. 2006 Mar 4;367(9512):731-9
references.pmid: 16517273
references.citation: J Infect Dis. 2010 Dec 15;202(12):1866-76
references.pmid: 21050125
references.citation: J Infect Dis. 2011 Jul 15;204(2):253-62
references.pmid: 21673036
references.citation: PLoS One. 2011;6(5):e19939
references.pmid: 21603642
references.citation: Infect Immun. 2009 May;77(5):2159-67
references.pmid: 19237525
references.citation: J Clin Invest. 2010 May;120(5):1762-73
references.pmid: 20364087
references.citation: Cytokine Growth Factor Rev. 2003 Oct;14(5):409-26
references.pmid: 12948524
references.citation: Microbes Infect. 2010 Jun;12(6):446-56
references.pmid: 20172045
references.citation: Nat Rev Microbiol. 2011 Mar;9(3):215-22
references.pmid: 21297670
references.citation: J Immunol. 2000 Apr 1;164(7):3713-22
references.pmid: 10725730
references.citation: Cell Microbiol. 2012 Oct;14(10):1600-19
references.pmid: 22694745
references.citation: Nat Immunol. 2007 Sep;8(9):950-7
references.pmid: 17676044
references.citation: PLoS One. 2012;7(5):e36532
references.pmid: 22574180
references.citation: Nat Med. 2011 Sep 18;17(10):1310-4
references.pmid: 21926978
references.citation: PLoS One. 2009;4(5):e5446
references.pmid: 19424507
references.citation: Infect Immun. 1989 Nov;57(11):3512-9
references.pmid: 2807534
references.citation: Clin Infect Dis. 2006 Mar 1;42(5):647-56
references.pmid: 16447110
references.citation: PLoS One. 2010 Dec 02;5(12):e15177
references.pmid: 21151999
references.citation: Nat Rev Immunol. 2011 Jul 01;11(8):505-18
references.pmid: 21720387
references.citation: Infect Immun. 1996 Aug;64(8):2974-9
references.pmid: 8757823
references.citation: Scand J Clin Lab Invest Suppl. 1968;97:77-89
references.pmid: 4179068
references.citation: N Engl J Med. 2006 Aug 17;355(7):666-74
references.pmid: 16914702
references.citation: J Immunol. 2009 Sep 15;183(6):3942-8
references.pmid: 19717510
references.citation: J Innate Immun. 2010;2(6):560-75
references.pmid: 20587998
references.citation: Cell Host Microbe. 2010 Jan 21;7(1):38-49
references.pmid: 20114027
references.citation: J Infect Dis. 2010 Oct 1;202(7):1050-8
references.pmid: 20726702
references.citation: Cytokine Growth Factor Rev. 2010 Dec;21(6):413-23
references.pmid: 21074482
references.citation: J Neuropathol Exp Neurol. 2004 Apr;63(4):381-96
references.pmid: 15099027
references.citation: Infect Immun. 2012 Sep;80(9):3161-9
references.pmid: 22733574
references.citation: J Leukoc Biol. 2005 Jul;78(1):14-26
references.pmid: 15784687
references.citation: J Infect Dis. 2012 Mar 1;205(5):807-17
references.pmid: 22279123
references.citation: Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13473-8
references.pmid: 20624979
references.citation: PLoS One. 2009;4(4):e5210
references.pmid: 19381294
references.citation: Infect Immun. 2011 Apr;79(4):1615-22
references.pmid: 21245272
references.citation: J Exp Med. 2008 Feb 18;205(2):287-94
references.pmid: 18268041
references.citation: J Infect Dis. 2008 Aug 15;198(4):561-70
references.pmid: 18598194
references.citation: Nat Immunol. 2007 Sep;8(9):942-9
references.pmid: 17676045
references.citation: JAMA. 2007 Oct 17;298(15):1763-71
references.pmid: 17940231
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12873-8
references.pmid: 19541630
references.citation: J Leukoc Biol. 2012 Nov;92(5):1069-81
references.pmid: 22892107
references.citation: J Immunol. 2008 Jan 1;180(1):500-9
references.pmid: 18097052
references.citation: J Exp Med. 2008 Jul 7;205(7):1551-7
references.pmid: 18591410
references.citation: Annu Rev Immunol. 2009;27:669-92
references.pmid: 19132917
references.citation: PLoS One. 2008 Jan 09;3(1):e1409
references.pmid: 18183290
references.citation: PLoS One. 2012;7(2):e31506
references.pmid: 22355374
references.citation: Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2809-15
references.pmid: 22639172
references.citation: PLoS One. 2011 Apr 15;6(4):e18617
references.pmid: 21525981
references.citation: Immunity. 2007 Oct;27(4):660-9
references.pmid: 17919942
references.citation: Cytokine Growth Factor Rev. 2002 Dec;13(6):455-81
references.pmid: 12401480
references.citation: J Immunol. 2011 Jan 1;186(1):443-52
references.pmid: 21131426
references.citation: Methods Cell Sci. 2002;24(1-3):79-90
references.pmid: 12815296
references.citation: Nature. 2012 Apr 26;484(7395):514-8
references.pmid: 22466287